02/23/2026 | Press release | Distributed by Public on 02/23/2026 09:55
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act File Number: 811-22293
T. Rowe Price U.S. Large-CapCore Fund, Inc.
(Exact name of registrant as specified in charter)
1307 Point Street, Baltimore, MD 21231
(Address of principal executive offices)
David Oestreicher
1307 Point Street, Baltimore, MD 21231
(Name and address of agent for service)
Registrant's telephone number, including area code: (410) 345-2000
Date of fiscal year end: December 31
Date of reporting period: December 31, 2025
Item 1. Reports to Shareholders
(a) Report pursuant to Rule 30e-1
Annual Shareholder Report
December 31, 2025
This annual shareholder report contains important information about U.S. Large-Cap Core Fund (the "fund") for the period of January 1, 2025 to December 31, 2025. You can find the fund's prospectus, financial information on Form N-CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1-800-638-5660 or [email protected]or contacting your intermediary.
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
|
U.S. Large-Cap Core Fund - Investor Class
|
$68
|
0.64%
|
U.S. large-cap stocks recorded a positive double-digit return in 2025 as anticipation of interest rate cuts by the Federal Reserve and rising valuations in the technology sector driven by artificial intelligence spending outweighed U.S. trade policy uncertainty, signs of labor market weakness, and a federal government shutdown.
The consumer discretionary sector contributed to relative performance versus the S&P 500 Index due to positive stock selection. Ulta Beauty was a key contributor as the beauty products retailer reported a string of better-than-expected earnings and gained share. The energy sector added value owing to favorable stock selection, driven by our holding in TechnipFMC, a UK oilfield services company.
Information technology detracted the most from relative returns due to adverse stock selection and an underweight to the sector, which outpaced the benchmark. Accenture, a Dublin, Ireland-headquartered management and technology consulting services company, was a large detractor. Health care weighed on relative performance owing to negative stock selection. Eli Lilly & Co. led performance detractors in the sector due to an underweight position in the drugmaker, whose shares surged over the period.
The fund relies on a core investing approach leveraging T. Rowe Price's fundamental research platform to identify large U.S. companies that appear to offer the most favorable combination of business fundamentals, earnings growth potential, and reasonable valuation. Sector allocations are driven by bottom-up stock selection. Industrials and business services was the largest overweight versus the benchmark at year-end. Conversely, health care was the largest underweight.
|
Investor Class
|
Regulatory Benchmark
|
Strategy Benchmark
|
|
|
2015
|
10,000
|
10,000
|
10,000
|
|
2016
|
9,984
|
10,097
|
10,135
|
|
2016
|
10,340
|
10,362
|
10,384
|
|
2016
|
10,633
|
10,818
|
10,784
|
|
2016
|
10,711
|
11,274
|
11,196
|
|
2017
|
11,514
|
11,921
|
11,875
|
|
2017
|
11,910
|
12,280
|
12,242
|
|
2017
|
12,200
|
12,842
|
12,790
|
|
2017
|
12,952
|
13,656
|
13,640
|
|
2018
|
12,881
|
13,568
|
13,537
|
|
2018
|
13,186
|
14,095
|
14,002
|
|
2018
|
14,089
|
15,099
|
15,081
|
|
2018
|
12,514
|
12,940
|
13,042
|
|
2019
|
14,074
|
14,757
|
14,822
|
|
2019
|
14,822
|
15,361
|
15,460
|
|
2019
|
15,009
|
15,540
|
15,723
|
|
2019
|
16,206
|
16,954
|
17,149
|
|
2020
|
13,026
|
13,410
|
13,788
|
|
2020
|
15,328
|
16,364
|
16,620
|
|
2020
|
16,721
|
17,871
|
18,105
|
|
2020
|
18,730
|
20,495
|
20,304
|
|
2021
|
19,750
|
21,796
|
21,558
|
|
2021
|
21,412
|
23,592
|
23,401
|
|
2021
|
21,394
|
23,568
|
23,537
|
|
2021
|
23,534
|
25,754
|
26,132
|
|
2022
|
22,241
|
24,395
|
24,931
|
|
2022
|
19,286
|
20,321
|
20,916
|
|
2022
|
18,347
|
19,413
|
19,895
|
|
2022
|
19,967
|
20,808
|
21,399
|
|
2023
|
20,787
|
22,302
|
23,004
|
|
2023
|
22,311
|
24,172
|
25,015
|
|
2023
|
21,929
|
23,386
|
24,196
|
|
2023
|
24,480
|
26,209
|
27,025
|
|
2024
|
27,748
|
28,835
|
29,878
|
|
2024
|
28,998
|
29,762
|
31,157
|
|
2024
|
29,912
|
31,616
|
32,992
|
|
2024
|
30,110
|
32,448
|
33,786
|
|
2025
|
29,057
|
30,916
|
32,343
|
|
2025
|
31,733
|
34,314
|
35,882
|
|
2025
|
33,517
|
37,120
|
38,797
|
|
2025
|
33,951
|
38,012
|
39,827
|
202501-4140694, 202601-5112879
F190-052 2/26
|
1 Year
|
5 Years
|
10 Years
|
|
|
U.S. Large-Cap Core Fund (Investor Class)
|
12.76%
|
12.63%
|
13.00%
|
|
Russell 3000 Index (Regulatory Benchmark)
|
17.15
|
13.15
|
14.29
|
|
S&P 500 Index (Strategy Benchmark)
|
17.88
|
14.42
|
14.82
|
The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund's performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund's returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares.The fund's past performance is not a good predictor of the fund's future performance.Updated performance information can be found at www.troweprice.com.
|
Information Technology
|
34.0%
|
|
Financials
|
12.6
|
|
Consumer Discretionary
|
10.5
|
|
Industrials & Business Services
|
9.9
|
|
Communication Services
|
9.7
|
|
Health Care
|
8.6
|
|
Consumer Staples
|
4.4
|
|
Energy
|
3.8
|
|
Materials
|
3.1
|
|
Other
|
3.4
|
|
NVIDIA
|
8.6%
|
|
Microsoft
|
8.1
|
|
Apple
|
7.8
|
|
Alphabet
|
5.9
|
|
Broadcom
|
3.6
|
|
Amazon.com
|
2.9
|
|
Visa
|
2.9
|
|
JPMorgan Chase
|
2.1
|
|
Bank of America
|
1.9
|
|
Meta Platforms
|
1.6
|
If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.
Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.
U.S. Large-Cap Core Fund
Investor Class (TRULX)
T. Rowe Price Investment Services, Inc.
1307 Point Street
Baltimore, Maryland 21231
Annual Shareholder Report
December 31, 2025
This annual shareholder report contains important information about U.S. Large-Cap Core Fund (the "fund") for the period of January 1, 2025 to December 31, 2025. You can find the fund's prospectus, financial information on Form N-CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1-800-638-5660 or [email protected]or contacting your intermediary.
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
|
U.S. Large-Cap Core Fund - Advisor Class
|
$103
|
0.97%
|
U.S. large-cap stocks recorded a positive double-digit return in 2025 as anticipation of interest rate cuts by the Federal Reserve and rising valuations in the technology sector driven by artificial intelligence spending outweighed U.S. trade policy uncertainty, signs of labor market weakness, and a federal government shutdown.
The consumer discretionary sector contributed to relative performance versus the S&P 500 Index due to positive stock selection. Ulta Beauty was a key contributor as the beauty products retailer reported a string of better-than-expected earnings and gained share. The energy sector added value owing to favorable stock selection, driven by our holding in TechnipFMC, a UK oilfield services company.
Information technology detracted the most from relative returns due to adverse stock selection and an underweight to the sector, which outpaced the benchmark. Accenture, a Dublin, Ireland-headquartered management and technology consulting services company, was a large detractor. Health care weighed on relative performance owing to negative stock selection. Eli Lilly & Co. led performance detractors in the sector due to an underweight position in the drugmaker, whose shares surged over the period.
The fund relies on a core investing approach leveraging T. Rowe Price's fundamental research platform to identify large U.S. companies that appear to offer the most favorable combination of business fundamentals, earnings growth potential, and reasonable valuation. Sector allocations are driven by bottom-up stock selection. Industrials and business services was the largest overweight versus the benchmark at year-end. Conversely, health care was the largest underweight.
|
Advisor Class
|
Regulatory Benchmark
|
Strategy Benchmark
|
|
|
2015
|
10,000
|
10,000
|
10,000
|
|
2016
|
9,979
|
10,097
|
10,135
|
|
2016
|
10,325
|
10,362
|
10,384
|
|
2016
|
10,609
|
10,818
|
10,784
|
|
2016
|
10,677
|
11,274
|
11,196
|
|
2017
|
11,469
|
11,921
|
11,875
|
|
2017
|
11,859
|
12,280
|
12,242
|
|
2017
|
12,139
|
12,842
|
12,790
|
|
2017
|
12,880
|
13,656
|
13,640
|
|
2018
|
12,799
|
13,568
|
13,537
|
|
2018
|
13,096
|
14,095
|
14,002
|
|
2018
|
13,983
|
15,099
|
15,081
|
|
2018
|
12,408
|
12,940
|
13,042
|
|
2019
|
13,949
|
14,757
|
14,822
|
|
2019
|
14,685
|
15,361
|
15,460
|
|
2019
|
14,853
|
15,540
|
15,723
|
|
2019
|
16,026
|
16,954
|
17,149
|
|
2020
|
12,873
|
13,410
|
13,788
|
|
2020
|
15,135
|
16,364
|
16,620
|
|
2020
|
16,505
|
17,871
|
18,105
|
|
2020
|
18,470
|
20,495
|
20,304
|
|
2021
|
19,469
|
21,796
|
21,558
|
|
2021
|
21,088
|
23,592
|
23,401
|
|
2021
|
21,052
|
23,568
|
23,537
|
|
2021
|
23,134
|
25,754
|
26,132
|
|
2022
|
21,845
|
24,395
|
24,931
|
|
2022
|
18,927
|
20,321
|
20,916
|
|
2022
|
17,993
|
19,413
|
19,895
|
|
2022
|
19,562
|
20,808
|
21,399
|
|
2023
|
20,352
|
22,302
|
23,004
|
|
2023
|
21,831
|
24,172
|
25,015
|
|
2023
|
21,443
|
23,386
|
24,196
|
|
2023
|
23,911
|
26,209
|
27,025
|
|
2024
|
27,089
|
28,835
|
29,878
|
|
2024
|
28,282
|
29,762
|
31,157
|
|
2024
|
29,153
|
31,616
|
32,992
|
|
2024
|
29,318
|
32,448
|
33,786
|
|
2025
|
28,273
|
30,916
|
32,343
|
|
2025
|
30,848
|
34,314
|
35,882
|
|
2025
|
32,562
|
37,120
|
38,797
|
|
2025
|
32,951
|
38,012
|
39,827
|
202501-4140694, 202601-5112879
F290-052 2/26
|
1 Year
|
5 Years
|
10 Years
|
|
|
U.S. Large-Cap Core Fund (Advisor Class)
|
12.39%
|
12.27%
|
12.66%
|
|
Russell 3000 Index (Regulatory Benchmark)
|
17.15
|
13.15
|
14.29
|
|
S&P 500 Index (Strategy Benchmark)
|
17.88
|
14.42
|
14.82
|
The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund's performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund's returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares.The fund's past performance is not a good predictor of the fund's future performance.Updated performance information can be found at www.troweprice.com.
|
Information Technology
|
34.0%
|
|
Financials
|
12.6
|
|
Consumer Discretionary
|
10.5
|
|
Industrials & Business Services
|
9.9
|
|
Communication Services
|
9.7
|
|
Health Care
|
8.6
|
|
Consumer Staples
|
4.4
|
|
Energy
|
3.8
|
|
Materials
|
3.1
|
|
Other
|
3.4
|
|
NVIDIA
|
8.6%
|
|
Microsoft
|
8.1
|
|
Apple
|
7.8
|
|
Alphabet
|
5.9
|
|
Broadcom
|
3.6
|
|
Amazon.com
|
2.9
|
|
Visa
|
2.9
|
|
JPMorgan Chase
|
2.1
|
|
Bank of America
|
1.9
|
|
Meta Platforms
|
1.6
|
If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.
Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.
U.S. Large-Cap Core Fund
Advisor Class (PAULX)
T. Rowe Price Investment Services, Inc.
1307 Point Street
Baltimore, Maryland 21231
Annual Shareholder Report
December 31, 2025
This annual shareholder report contains important information about U.S. Large-Cap Core Fund (the "fund") for the period of January 1, 2025 to December 31, 2025. You can find the fund's prospectus, financial information on Form N-CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1-800-638-5660 or [email protected]or contacting your intermediary.
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
|
U.S. Large-Cap Core Fund - I Class
|
$61
|
0.57%
|
U.S. large-cap stocks recorded a positive double-digit return in 2025 as anticipation of interest rate cuts by the Federal Reserve and rising valuations in the technology sector driven by artificial intelligence spending outweighed U.S. trade policy uncertainty, signs of labor market weakness, and a federal government shutdown.
The consumer discretionary sector contributed to relative performance versus the S&P 500 Index due to positive stock selection. Ulta Beauty was a key contributor as the beauty products retailer reported a string of better-than-expected earnings and gained share. The energy sector added value owing to favorable stock selection, driven by our holding in TechnipFMC, a UK oilfield services company.
Information technology detracted the most from relative returns due to adverse stock selection and an underweight to the sector, which outpaced the benchmark. Accenture, a Dublin, Ireland-headquartered management and technology consulting services company, was a large detractor. Health care weighed on relative performance owing to negative stock selection. Eli Lilly & Co. led performance detractors in the sector due to an underweight position in the drugmaker, whose shares surged over the period.
The fund relies on a core investing approach leveraging T. Rowe Price's fundamental research platform to identify large U.S. companies that appear to offer the most favorable combination of business fundamentals, earnings growth potential, and reasonable valuation. Sector allocations are driven by bottom-up stock selection. Industrials and business services was the largest overweight versus the benchmark at year-end. Conversely, health care was the largest underweight.
|
I Class
|
Regulatory Benchmark
|
Strategy Benchmark
|
|
|
11/29/16
|
500,000
|
500,000
|
500,000
|
|
12/31/16
|
502,912
|
508,515
|
508,640
|
|
3/31/17
|
541,101
|
537,720
|
539,495
|
|
6/30/17
|
559,948
|
553,935
|
556,155
|
|
9/30/17
|
573,835
|
579,257
|
581,073
|
|
12/31/17
|
609,134
|
615,967
|
619,684
|
|
3/31/18
|
606,066
|
611,997
|
614,980
|
|
6/30/18
|
620,898
|
635,796
|
636,097
|
|
9/30/18
|
663,603
|
681,090
|
685,145
|
|
12/31/18
|
589,488
|
583,679
|
592,515
|
|
3/31/19
|
663,518
|
665,648
|
673,381
|
|
6/30/19
|
699,019
|
692,907
|
702,362
|
|
9/30/19
|
707,826
|
700,962
|
714,290
|
|
12/31/19
|
764,729
|
764,731
|
779,076
|
|
3/31/20
|
614,810
|
604,904
|
626,393
|
|
6/30/20
|
723,894
|
738,150
|
755,075
|
|
9/30/20
|
789,858
|
806,115
|
822,499
|
|
12/31/20
|
885,218
|
924,466
|
922,417
|
|
3/31/21
|
933,675
|
983,141
|
979,376
|
|
6/30/21
|
1,012,131
|
1,064,150
|
1,063,101
|
|
9/30/21
|
1,011,554
|
1,063,067
|
1,069,289
|
|
12/31/21
|
1,112,636
|
1,161,694
|
1,187,201
|
|
3/31/22
|
1,051,806
|
1,100,375
|
1,132,607
|
|
6/30/22
|
912,144
|
916,599
|
950,245
|
|
9/30/22
|
867,763
|
875,677
|
903,848
|
|
12/31/22
|
944,850
|
938,568
|
972,188
|
|
3/31/23
|
983,732
|
1,005,960
|
1,045,074
|
|
6/30/23
|
1,055,989
|
1,090,328
|
1,136,436
|
|
9/30/23
|
1,038,168
|
1,054,851
|
1,099,236
|
|
12/31/23
|
1,158,954
|
1,182,191
|
1,227,754
|
|
3/31/24
|
1,313,959
|
1,300,639
|
1,357,354
|
|
6/30/24
|
1,373,225
|
1,342,467
|
1,415,501
|
|
9/30/24
|
1,416,861
|
1,426,091
|
1,498,825
|
|
12/31/24
|
1,426,484
|
1,463,644
|
1,534,934
|
|
3/31/25
|
1,376,828
|
1,394,532
|
1,469,359
|
|
6/30/25
|
1,503,920
|
1,547,808
|
1,630,142
|
|
9/30/25
|
1,588,995
|
1,674,360
|
1,762,584
|
|
12/31/25
|
1,609,394
|
1,714,593
|
1,809,380
|
202501-4140694, 202601-5112879
F310-052 2/26
|
1 Year
|
5 Years
|
Since Inception 11/29/16
|
|
|
U.S. Large-Cap Core Fund (I Class)
|
12.82%
|
12.70%
|
13.73%
|
|
Russell 3000 Index (Regulatory Benchmark)
|
17.15
|
13.15
|
14.52
|
|
S&P 500 Index (Strategy Benchmark)
|
17.88
|
14.42
|
15.20
|
The preceding line graph shows the value of a hypothetical $500,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund's performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund's returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares.The fund's past performance is not a good predictor of the fund's future performance.Updated performance information can be found at www.troweprice.com.
|
Information Technology
|
34.0%
|
|
Financials
|
12.6
|
|
Consumer Discretionary
|
10.5
|
|
Industrials & Business Services
|
9.9
|
|
Communication Services
|
9.7
|
|
Health Care
|
8.6
|
|
Consumer Staples
|
4.4
|
|
Energy
|
3.8
|
|
Materials
|
3.1
|
|
Other
|
3.4
|
|
NVIDIA
|
8.6%
|
|
Microsoft
|
8.1
|
|
Apple
|
7.8
|
|
Alphabet
|
5.9
|
|
Broadcom
|
3.6
|
|
Amazon.com
|
2.9
|
|
Visa
|
2.9
|
|
JPMorgan Chase
|
2.1
|
|
Bank of America
|
1.9
|
|
Meta Platforms
|
1.6
|
If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.
Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.
U.S. Large-Cap Core Fund
I Class (RCLIX)
T. Rowe Price Investment Services, Inc.
1307 Point Street
Baltimore, Maryland 21231
Annual Shareholder Report
December 31, 2025
This annual shareholder report contains important information about U.S. Large-Cap Core Fund (the "fund") for the period of January 1, 2025 to December 31, 2025. You can find the fund's prospectus, financial information on Form N-CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1-800-638-5660 or [email protected]or contacting your intermediary.
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
|
U.S. Large-Cap Core Fund - Z Class
|
$0
|
0.00%
|
U.S. large-cap stocks recorded a positive double-digit return in 2025 as anticipation of interest rate cuts by the Federal Reserve and rising valuations in the technology sector driven by artificial intelligence spending outweighed U.S. trade policy uncertainty, signs of labor market weakness, and a federal government shutdown.
The consumer discretionary sector contributed to relative performance versus the S&P 500 Index due to positive stock selection. Ulta Beauty was a key contributor as the beauty products retailer reported a string of better-than-expected earnings and gained share. The energy sector added value owing to favorable stock selection, driven by our holding in TechnipFMC, a UK oilfield services company.
Information technology detracted the most from relative returns due to adverse stock selection and an underweight to the sector, which outpaced the benchmark. Accenture, a Dublin, Ireland-headquartered management and technology consulting services company, was a large detractor. Health care weighed on relative performance owing to negative stock selection. Eli Lilly & Co. led performance detractors in the sector due to an underweight position in the drugmaker, whose shares surged over the period.
The fund relies on a core investing approach leveraging T. Rowe Price's fundamental research platform to identify large U.S. companies that appear to offer the most favorable combination of business fundamentals, earnings growth potential, and reasonable valuation. Sector allocations are driven by bottom-up stock selection. Industrials and business services was the largest overweight versus the benchmark at year-end. Conversely, health care was the largest underweight.
|
Z Class
|
Regulatory Benchmark
|
Strategy Benchmark
|
|
|
3/16/20
|
10,000
|
10,000
|
10,000
|
|
3/31/20
|
10,864
|
10,865
|
10,839
|
|
6/30/20
|
12,808
|
13,259
|
13,066
|
|
9/30/20
|
14,000
|
14,480
|
14,233
|
|
12/31/20
|
15,709
|
16,606
|
15,962
|
|
3/31/21
|
16,595
|
17,659
|
16,947
|
|
6/30/21
|
18,020
|
19,115
|
18,396
|
|
9/30/21
|
18,030
|
19,095
|
18,503
|
|
12/31/21
|
19,864
|
20,867
|
20,544
|
|
3/31/22
|
18,802
|
19,765
|
19,599
|
|
6/30/22
|
16,328
|
16,464
|
16,443
|
|
9/30/22
|
15,559
|
15,729
|
15,640
|
|
12/31/22
|
16,960
|
16,859
|
16,823
|
|
3/31/23
|
17,685
|
18,069
|
18,084
|
|
6/30/23
|
19,013
|
19,585
|
19,665
|
|
9/30/23
|
18,718
|
18,948
|
19,021
|
|
12/31/23
|
20,929
|
21,235
|
21,245
|
|
3/31/24
|
23,764
|
23,362
|
23,488
|
|
6/30/24
|
24,871
|
24,114
|
24,494
|
|
9/30/24
|
25,697
|
25,616
|
25,936
|
|
12/31/24
|
25,908
|
26,290
|
26,561
|
|
3/31/25
|
25,042
|
25,049
|
25,426
|
|
6/30/25
|
27,388
|
27,802
|
28,208
|
|
9/30/25
|
28,981
|
30,075
|
30,500
|
|
12/31/25
|
29,396
|
30,798
|
31,310
|
202501-4140694, 202601-5112879
F1270-052 2/26
|
1 Year
|
5 Years
|
Since Inception 3/16/20
|
|
|
U.S. Large-Cap Core Fund (Z Class)
|
13.46%
|
13.35%
|
20.45%
|
|
Russell 3000 Index (Regulatory Benchmark)
|
17.15
|
13.15
|
21.42
|
|
S&P 500 Index (Strategy Benchmark)
|
17.88
|
14.42
|
21.77
|
The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund's performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund's returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares.The fund's past performance is not a good predictor of the fund's future performance.Updated performance information can be found at www.troweprice.com.
|
Information Technology
|
34.0%
|
|
Financials
|
12.6
|
|
Consumer Discretionary
|
10.5
|
|
Industrials & Business Services
|
9.9
|
|
Communication Services
|
9.7
|
|
Health Care
|
8.6
|
|
Consumer Staples
|
4.4
|
|
Energy
|
3.8
|
|
Materials
|
3.1
|
|
Other
|
3.4
|
|
NVIDIA
|
8.6%
|
|
Microsoft
|
8.1
|
|
Apple
|
7.8
|
|
Alphabet
|
5.9
|
|
Broadcom
|
3.6
|
|
Amazon.com
|
2.9
|
|
Visa
|
2.9
|
|
JPMorgan Chase
|
2.1
|
|
Bank of America
|
1.9
|
|
Meta Platforms
|
1.6
|
If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.
Frank Russell Company "LSE" and S&P do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit www.troweprice.com/en/us/market-data-disclosures for additional legal notices & disclaimers.
U.S. Large-Cap Core Fund
Z Class (TRZLX)
T. Rowe Price Investment Services, Inc.
1307 Point Street
Baltimore, Maryland 21231
Item 1. (b) Notice pursuant to Rule 30e-3.
Not applicable.
Item 2. Code of Ethics.
The registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR,applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of this code of ethics is filed as an exhibit to this Form N-CSR.No substantive amendments were approved or waivers were granted to this code of ethics during the period covered by this report.
Item 3. Audit Committee Financial Expert.
The registrant's Board of Directors has determined that Mr. Paul F. McBride qualifies as an audit committee financial expert, as defined in Item 3 of Form N-CSR.Mr. McBride is considered independent for purposes of Item 3 of Form N-CSR.
Item 4. Principal Accountant Fees and Services.
(a) - (d) Aggregate fees billed for the last two fiscal years for professional services rendered to, or on behalf of, the registrant by the registrant's principal accountant were as follows:
|
2025 |
2024 |
|||||||||
|
Audit Fees |
$ | 23,735 | $ | 23,525 | ||||||
|
Audit-Related Fees |
- | - | ||||||||
|
Tax Fees |
125 | - | ||||||||
|
All Other Fees |
- | - | ||||||||
Audit fees include amounts related to the audit of the registrant's annual financial statements and services normally provided by the accountant in connection with statutory and regulatory filings. Audit-related fees include amounts reasonably related to the performance of the audit of the registrant's financial statements and specifically include the issuance of a report on internal controls and, if applicable, agreed-upon procedures related to fund acquisitions. Tax fees include amounts related to services for tax compliance, tax planning, and tax advice. The nature of these services specifically includes the review of distribution calculations and the preparation of Federal, state, and excise tax returns. All other fees include the registrant's pro-ratashare of amounts for agreed-upon procedures in conjunction with service contract approvals by the registrant's Board of Directors/Trustees.
(e)(1) The registrant's audit committee has adopted a policy whereby audit and non-auditservices performed by the registrant's principal accountant for the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant require pre-approvalin advance at regularly scheduled audit committee meetings. If such a service is required between regularly scheduled audit committee meetings, pre-approvalmay be authorized by one audit committee member with ratification at the next scheduled audit committee meeting. Waiver of pre-approvalfor audit or non-auditservices requiring fees of a de minimis amount is not permitted.
(2) No services included in (b) - (d) above were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01of Regulation S-X.
(f) Less than 50 percent of the hours expended on the principal accountant's engagement to audit the registrant's financial statements for the most recent fiscal year were attributed to work performed by persons other than the principal accountant's full-time, permanent employees.
(g) The aggregate fees billed for the most recent fiscal year and the preceding fiscal year by the registrant's principal accountant for non-auditservices rendered to the registrant, its investment adviser, and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant were $1,862,000 and $1,262,000, respectively.
(h) All non-auditservices rendered in (g) above were pre-approvedby the registrant's audit committee. Accordingly, these services were considered by the registrant's audit committee in maintaining the principal accountant's independence.
(i) Not applicable.
(j) Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) Not applicable. The complete schedule of investments is included in Item 7 of this Form N-CSR.
(b) Not applicable.
Item 7. Financial Statements and Financial Highlights for Open-EndManagement Investment Companies.
(a - b) Report pursuant to Regulation S-X.
Item 8. Changes in and Disagreements with Accountants for Open-EndManagement Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-EndManagement Investment Companies.
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-EndManagement Investment Companies.
Remuneration paid to Directors is included in Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
If applicable, see Item 7.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-EndManagement Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-EndManagement Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-EndManagement Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There has been no change to the procedures by which shareholders may recommend nominees to the registrant's board of directors.
Item 16. Controls and Procedures.
(a) The registrant's principal executive officer and principal financial officer have evaluated the registrant's disclosure controls and procedures within 90 days of this filing and have concluded that the registrant's disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSRwas recorded, processed, summarized, and reported timely.
(b) The registrant's principal executive officer and principal financial officer are aware of no change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
Item 17. Disclosure of Securities Lending Activities for Closed-EndManagement Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
| (a)(1) |
N-CSR |
|
| (2) |
Listing standards relating to recovery of erroneously awarded compensation: not applicable. |
|
| (3) |
30a-2(a) |
|
| (b) |
30a-2(b) |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| T. Rowe Price U.S. Large-CapCore Fund, Inc. | ||||
| By |
/s/ David Oestreicher |
|||
| David Oestreicher | ||||
| Principal Executive Officer | ||||
| Date | February 18, 2026 | |||
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By |
/s/ David Oestreicher |
|||
| David Oestreicher | ||||
| Principal Executive Officer | ||||
| Date |
February 18, 2026 |
|||
| By |
/s/ Alan S. Dupski |
|||
| Alan S. Dupski | ||||
| Principal Financial Officer | ||||
| Date |
February 18, 2026 |
|||